Mometasone topical Alternatives Compared
| Mometasone topical | Dupixent (dupilumab) | Triamcinolone topical |
|
|---|
| Mometasone topical | Dupixent (dupilumab) | Triamcinolone topical |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Eczema, Atopic Dermatitis, Psoriasis, Dermatitis, Allergies. Mometasone topical may also be used for purposes not listed in this medication guide. |
Prescription only
Dupixent injection is usually given every 1 to 4 weeks to treat asthma, eczema, chronic rhinosinusitis, COPD, eosinophilic esophagitis, chronic urticaria, or prurigo nodularis. Injection site... View more |
Prescription only
Prescribed for Lichen Planus, Atopic Dermatitis, Dermatitis, Aphthous Ulcer, Psoriasis, Eczema, Stomatitis, Allergies. Triamcinolone topical may also be used for purposes not listed in this medication guide. View more |
Related suggestions Atopic Dermatitis
Eczema
Popular comparisons
|
|||||||||||||||||||||||
| More about Mometasone topical | More about Dupixent (dupilumab) | More about Triamcinolone topical | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Mometasone topical has an average rating of 8.8 out of 10 from a total of 92 ratings on Drugs.com. 88% of reviewers reported a positive effect, while 8% reported a negative effect. |
Dupixent has an average rating of 7.3 out of 10 from a total of 504 ratings on Drugs.com. 62% of reviewers reported a positive effect, while 19% reported a negative effect. |
Triamcinolone topical has an average rating of 7.7 out of 10 from a total of 107 ratings on Drugs.com. 70% of reviewers reported a positive effect, while 19% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
View all Mometasone topical side effects |
View all Dupixent side effects |
View all Triamcinolone topical side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
N/A |
Lower cost generic |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Mometasone topical prices |
View all Dupixent prices |
View all Triamcinolone topical prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Elocon |
N/A |
Aricin, Aristocort A, Aristocort R, Cinalog, Cinolar, Delta-Tritex, DermacinRx Silazone, DermacinRx Trizapak, Dermasorb TA, Juulissa Pharmapak, Kenalog, Kourzeq, Oralone, SilaLite Pak, Treziopak, Trianex, Triasil, Triderm, Tritocin View more | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 50 drugs are known to interact with Mometasone topical:
|
A total of 94 drugs are known to interact with Dupixent:
|
A total of 48 drugs are known to interact with Triamcinolone topical:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
April 30, 1987 |
March 28, 2017 |
October 23, 1958 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
||||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Skyrizi
Skyrizi (risankizumab) is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis ...
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Zyrtec
Zyrtec (cetirizine) is used to treat allergy symptoms such as sneezing, itching, watery eyes, or ...
Humira
Humira is a tumor necrosis factor blocker that is used to treat many inflammatory conditions such ...
Benadryl
Benadryl is an antihistamine and is used to treat sneezing, runny nose, itching and other ...
Flonase
Flonase (fluticasone nasal) is used to treat nasal congestion, sneezing, and runny nose caused by ...
Claritin
Claritin is an antihistamine used to treat the symptoms of allergies, such as sneezing, watery ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.